Weight Loss Pill Also Lowers Blood Pressure. May 4, 2. 01. 0 (New York) - - An experimental weight loss/blood pressure pill may pack a one- two punch against hunger and high blood pressure, one of the main health consequences of obesity, according to new research presented at the American Society of Hypertension’s 2. New York. Taken once a day, Qnexa combines the appetite suppressantphentermine with the anti- seizure drug topiramate in a unique formulation. Data on this drug are slated to be reviewed this summer by an FDA advisory panel. The FDA is not obligated to follow the advice of its expert panels, but it usually does. Phentermine quickly suppresses appetite, while the controlled- release topiramate decreases appetite and increases satiety throughout the day. Topiramate also has blood pressure- lowering effects, she says. Oparil is a consultant for Qnexa manufacturer Vivus. The new analysis of three separate studies included more than 4,5. Researchers compared several doses of the new pill with placebo among severely obese adults, as well as overweight, nonobese people who had other health problems related to their weight, such as high blood pressure or metabolic syndrome, a cluster of risk factors that increase risk for diabetes and heart disease. Overall, people who took the combination pill lost more weight than their counterparts who were given a placebo. The higher the dose, the more substantial the weight loss, and the more likely it was to be maintained over time, the study shows. At six months, people who took the full dose of Qnexa once daily lost nearly 1. Those who took the medium dose of the pill lost 8% of their body weight at six months and 8.
The people who took the lowest dose of the drug dropped about 5. Continued. The new drug also resulted in drops in systolic blood pressure - - the upper number in a blood pressure reading - - at one year. Or you lose a bit, then gain it back with a vengeance. Sound familiar? Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 1-888-INFO-FDA (1-888-463-6332) Contact FDA. A sub- analysis of people with high blood pressure showed that the new pill also helped reduce blood pressure in this group and allowed them to reduce the number of other blood pressure medications they were taking. The new pill did have some side effects, including altered taste, constipation, dizziness, dry mouth, and headache. But “there were no surprises,” Oparil says.“It was safe and efficacious across a broad patient population - - some who were very obese and some who were less obese, but had metabolic syndrome or high blood pressure,” she says. Phentermine was once widely prescribed as the “phen” part of the fen- phen weight loss combo that shot to fame in the mid- 1. The problems were found to be related to the “fen” or fenfluramine part of the combination, not the phentermine. Louis Aronne, MD, founder and director of the Comprehensive Weight Control Program at New York- Presbyterian Hospital/Weill Cornell Medical Center in New York, believes that combination drugs such as Qnexa hold promise in the battle of the bulge.“Instead of using single agents, we need to use combination drugs to break through the . A BMI takes height and weight into account to measure body fat. If your BMI is greater than 2. If it is over 3. 0, you are considered obese. Continued. Some people are candidates for weight loss surgery, and others who are just slightly overweight may be able get by with proper diet and exercise, Aronne says.“The one- third of people who fall in the middle and have all the risks and complications of obesity - - that is where I see this drug having an application,” he says. American Society of Hypertension President George Bakris, MD, a professor of medicine and the director of the Hypertension Center at the University of Chicago, is cautiously optimistic about the potential benefits of this new drug.“I would like to see a 2. All rights reserved. Couch Potatoes Rejoice! Repackaged Fen- Phen Approvedby Sarah Updated: April 0. Comments: 7. 0For those who prefer losing weight from the comfort of their living room couch while watching TV and eating a bag of potato chips with a large diet soda, the FDA has a new drug for you! The new anti- obesity drug Qsymia manufactured by Vivus Inc. Overweight and obese people will likely total 8. Qsymia Nothing More than Repackaged Fen- Phen. The new anti- obesity drug Qsymia was created using two older drugs: topiramate and phentermine. When it is yanked off the market for harming people (again), just settle the lawsuits. Just a normal cost of doing business, right? In the end, Vivus will likely make much much more than will ever be paid out in future lawsuits from Qsymia, so it is a sound business decision for shareholders to get it out there and get the revenue flowing quickly. This strategy is, of course, unethical, but it is perfectly legal and a proven way to generate huge profits for the drug industry in a short period of time. Qsymia Side Effects. Acknowledged side effects of Qsymia include tingling in the hands and feet, constipation, dry mouth, dizziness, and insomnia. Wait a minute – insomnia? A patient prescribed Qsymia will take on all this unknown health risk from taking a drug that was previously removed from the market over 1. Worse, he/she probably won’t lose that much weight either. Hint: If you would like to know how long it takes to lose weight, this article tells you exactly with no gimmicks! Documentation submitted to the FDA indicated that nearly 7. Qsymia for an entire year lost only 5% of their body weight. This compares with 2. This means that a 2. Qsymia for a full year. Since the average American consumes 6. Eat grassfed beef or take a new anti- obesity drug with many side effects that will no doubt be prescribed for children as well? That’s an easy choice. Sarah, The Healthy Home Economist. Source: Obesity Pill Qsymia Gains FDA Approval.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
August 2017
Categories |